Tryp Therapeutics Partners with Fluence for Psychotherapy Design Post published:May 3, 2021 Post category:Press Release
Mydecine Reports Full Year 2020 Financial Results and Provides Business Update Post published:May 3, 2021 Post category:Press Release
Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities Post published:May 3, 2021 Post category:Press Release
COMPASS Pathways announces pricing of public offering Post published:April 30, 2021 Post category:Press Release
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation Post published:April 29, 2021 Post category:Press Release
Tryp Therapeutics Announces Q2 2021 Financial Results Post published:April 29, 2021 Post category:Press Release
Small Pharma Completes Reverse Take-Over Transaction Post published:April 29, 2021 Post category:Press Release
MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM’s Market Launch, Delivering Mental Wealth Post published:April 29, 2021 Post category:Press Release
Lobe Sciences Announces Filing of PCT Application Post published:April 29, 2021 Post category:Press Release
BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs Post published:April 29, 2021 Post category:Press Release